Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Economic evaluations and diabetes.

D S Pathak1, T A Burke

  • 1Ohio State University College of Pharmacy, Columbus 43210, USA.

Pharmacy Practice Management Quarterly
|December 8, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

International cross-cultural validation study of the Canadian haemophilia outcomes: kids' life assessment tool.

Haemophilia : the official journal of the World Federation of Hemophilia·2014
Same author

Process and experience of cross-cultural adaptation of a quality of life measure (CHO-KLAT) for boys with haemophilia in Brazil.

Haemophilia : the official journal of the World Federation of Hemophilia·2013
Same author

Health care services utilization stratified by virological and immunological markers of HIV: evidence from a universal health care setting.

HIV medicine·2009
Same author

Validation of the eleven-point pain scale in the measurement of migraine headache pain.

Cephalalgia : an international journal of headache·2007
Same author

Cost-effectiveness of losartan-based therapy in patients with hypertension and left ventricular hypertrophy: a UK-based economic evaluation of the Losartan Intervention for Endpoint reduction in hypertension (LIFE) study.

Journal of human hypertension·2005
Same author

A test of worker policing theory in an advanced eusocial wasp, Vespula rufa.

Evolution; international journal of organic evolution·2005
Same journal

Survey of standards and guidelines for immunization delivery.

Pharmacy practice management quarterly·2001
Same journal

Somebody else's antibodies: the characteristics and roles of immune globulins.

Pharmacy practice management quarterly·2001
Same journal

Targeting vaccines based on underlying disease states.

Pharmacy practice management quarterly·2001
Same journal

Overcoming immunization disparities based on ethnicity.

Pharmacy practice management quarterly·2001
Same journal

Immunization and organ transplant donors and recipients.

Pharmacy practice management quarterly·2001
Same journal

Pregnancy and lactation in relation to vaccines and antibodies.

Pharmacy practice management quarterly·2001
See all related articles

Economic evaluations are crucial for understanding the financial burden of diabetes and comparing treatment costs and benefits. This approach helps healthcare professionals make informed decisions with limited resources.

Area of Science:

  • Health Economics
  • Diabetes Management

Background:

  • Diabetes and its complications incur substantial economic costs, estimated at $85-$105 billion in the US in 1992.
  • Healthcare professionals require methods to assess illness burden and treatment value within resource constraints.

Purpose of the Study:

  • To review economic evaluation techniques applicable to diabetes care.
  • To guide healthcare professionals in comparing treatment alternatives based on benefits and costs.

Main Methods:

  • Literature review of economic evaluation studies in the diabetes field.
  • Analysis of full and partial economic evaluation methodologies.

Main Results:

  • Economic evaluation provides a framework for assessing the value of diabetes treatments.

Related Experiment Videos

  • Specific techniques for combining benefits and costs are discussed.

    • Conclusions:

    • Economic evaluation is essential for informed decision-making in diabetes management.
    • Understanding cost-benefit analyses aids in optimizing resource allocation for diabetes care.